BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dayabandara M, Hanwella R, Ratnatunga S, Seneviratne S, Suraweera C, de Silva VA. Antipsychotic-associated weight gain: management strategies and impact on treatment adherence. Neuropsychiatr Dis Treat 2017;13:2231-41. [PMID: 28883731 DOI: 10.2147/NDT.S113099] [Cited by in Crossref: 118] [Cited by in F6Publishing: 68] [Article Influence: 23.6] [Reference Citation Analysis]
Number Citing Articles
1 Alphs L, Brown B, Turkoz I, Baker P, Fu DJ, Nuechterlein KH. The Disease Recovery Evaluation and Modification (DREaM) study: Effectiveness of paliperidone palmitate versus oral antipsychotics in patients with recent-onset schizophrenia or schizophreniform disorder. Schizophr Res 2022;243:86-97. [PMID: 35247794 DOI: 10.1016/j.schres.2022.02.019] [Reference Citation Analysis]
2 Heald A, Azadbakht N, Geary B, Conen S, Fachim H, Lee DCH, Geifman N, Farman S, Howes O, Whetton A, Deakin B. Application of SWATH mass spectrometry in the identification of circulating proteins does not predict future weight gain in early psychosis. Clin Proteomics 2020;17:38. [PMID: 33117088 DOI: 10.1186/s12014-020-09299-2] [Reference Citation Analysis]
3 Nerland S, Stokkan TS, Jørgensen KN, Wortinger LA, Richard G, Beck D, van der Meer D, Westlye LT, Andreassen OA, Agartz I, Barth C. A comparison of intracranial volume estimation methods and their cross-sectional and longitudinal associations with age. Hum Brain Mapp 2022. [PMID: 35708198 DOI: 10.1002/hbm.25978] [Reference Citation Analysis]
4 Zapata RC, Rosenthal SB, Fisch K, Dao K, Jain M, Osborn O. Metabolomic profiles associated with a mouse model of antipsychotic-induced food intake and weight gain. Sci Rep 2020;10:18581. [PMID: 33122657 DOI: 10.1038/s41598-020-75624-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Doane MJ, Bessonova L, Friedler HS, Mortimer KM, Cheng H, Brecht T, O'Sullivan AK, Cummings H, McDonnell D, Meyer JM. Weight gain and comorbidities associated with oral second-generation antipsychotics: analysis of real-world data for patients with schizophrenia or bipolar I disorder. BMC Psychiatry 2022;22:114. [PMID: 35164737 DOI: 10.1186/s12888-022-03758-w] [Reference Citation Analysis]
6 de Boer N, Guloksuz S, van Baal C, Willebrands L, Deenik J, Vinkers CH, Rossum IW, Zinkstok J, Wilting I, Zantvoord JB, Backx F, Swildens WE, Schouw M, Bogers J, Hulshof F, de Knijff R, Duindam P, Veereschild M, Bak M, Frederix G, de Haan L, van Os J, Cahn W, Luykx JJ. Study protocol of a randomized, double-blind, placebo-controlled, multi-center trial to treat antipsychotic-induced weight gain: the Metformin-Lifestyle in antipsychotic users (MELIA) trial. BMC Psychiatry 2021;21:4. [PMID: 33402159 DOI: 10.1186/s12888-020-02992-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Savitz AJ, Xu H, Gopal S, Nuamah I, Ravenstijn P, Hough D, Hargarter L. Efficacy and safety of paliperidone palmitate 3-month versus 1-month formulation in patients with schizophrenia: comparison between European and non-European population. Neuropsychiatr Dis Treat 2019;15:587-602. [PMID: 30863080 DOI: 10.2147/NDT.S189668] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ellul P, Delorme R, Cortese S. Metformin for Weight Gain Associated with Second-Generation Antipsychotics in Children and Adolescents: A Systematic Review and Meta-Analysis. CNS Drugs 2018;32:1103-12. [PMID: 30238318 DOI: 10.1007/s40263-018-0571-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 6.7] [Reference Citation Analysis]
9 Skonieczna-Żydecka K, Łoniewski I, Misera A, Stachowska E, Maciejewska D, Marlicz W, Galling B. Second-generation antipsychotics and metabolism alterations: a systematic review of the role of the gut microbiome. Psychopharmacology (Berl) 2019;236:1491-512. [PMID: 30460516 DOI: 10.1007/s00213-018-5102-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 8.5] [Reference Citation Analysis]
10 Li H, Peng S, Li S, Liu S, Lv Y, Yang N, Yu L, Deng YH, Zhang Z, Fang M, Huo Y, Chen Y, Sun T, Li W. Chronic olanzapine administration causes metabolic syndrome through inflammatory cytokines in rodent models of insulin resistance. Sci Rep 2019;9:1582. [PMID: 30733507 DOI: 10.1038/s41598-018-36930-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
11 Cheng P, Wang L, Xu L, Zhou Y, Zhang L, Li W. Factors Related to the Length of Stay for Patients With Schizophrenia: A Retrospective Study. Front Psychiatry 2022;12:818254. [DOI: 10.3389/fpsyt.2021.818254] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Goh KK, Chen CY, Wu T, Chen C, Lu M. Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction. IJMS 2022;23:7092. [DOI: 10.3390/ijms23137092] [Reference Citation Analysis]
13 Arango C, Ng-Mak D, Finn E, Byrne A, Loebel A. Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysis. Eur Child Adolesc Psychiatry 2020;29:1195-205. [PMID: 31758359 DOI: 10.1007/s00787-019-01425-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
14 Coughlin JW, Steffen KJ, Sockalingam S, Mitchell JE. Psychotropic Medications in Metabolic and Bariatric Surgery: Research Updates and Clinical Considerations. Curr Psychiatry Rep. [DOI: 10.1007/s11920-022-01317-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Harjaningsih W, Ayunirrahmah L, Putri NJV. The therapeutic outcomes and adverse drug reactions study of Clozapine on Schizophrenia inpatients in the Grhasia psychiatric hospital Yogyakarta, Indonesia. PE. [DOI: 10.46542/pe.2021.212.287295] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Sudarshan Y, Cheung BMY. Hypertension and psychosis. Postgrad Med J 2022:postgradmedj-2021-141386. [PMID: 35074801 DOI: 10.1136/postgradmedj-2021-141386] [Reference Citation Analysis]
17 Nagy LR, Rice T, Coffey BJ. Combined Topiramate and Metformin Pharmacotherapy for Second-Generation Antipsychotic-Induced Weight Gain in Pediatric Bipolar Disorder and Aggression. J Child Adolesc Psychopharmacol 2022;32:72-6. [PMID: 35166568 DOI: 10.1089/cap.2022.29215.bjc] [Reference Citation Analysis]
18 Kang D, Jing Z, Li R, Hei G, Shao T, Li L, Sun M, Yang Y, Wang Y, Wang X, Long Y, Huang X, Wu R. Effect of Betahistine and Metformin on Antipsychotic-Induced Weight Gain: An Analysis of Two Clinical Trials. Front Psychiatry 2018;9:620. [PMID: 30542300 DOI: 10.3389/fpsyt.2018.00620] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
19 Abbas MM, Soto P, Ramalingam L, El-Manzalawy Y, Bensmail H, Moustaid-Moussa N. Sex Differences in Fish Oil and Olanzapine Effects on Gut Microbiota in Diet-Induced Obese Mice. Nutrients 2022;14:349. [PMID: 35057526 DOI: 10.3390/nu14020349] [Reference Citation Analysis]
20 Faden J, Serdenes R, Citrome L. Olanzapine-samidorphan combination tablets for the treatment of schizophrenia and bipolar I disorder - what is it, and will it be used? Expert Rev Neurother 2022. [PMID: 35354374 DOI: 10.1080/14737175.2022.2060742] [Reference Citation Analysis]
21 Endomba FT, Tankeu AT, Nkeck JR, Tochie JN. Leptin and psychiatric illnesses: does leptin play a role in antipsychotic-induced weight gain? Lipids Health Dis 2020;19:22. [PMID: 32033608 DOI: 10.1186/s12944-020-01203-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
22 Weizman S, Shelef A, Bloemhof Bris E, Stryjer R. A Double-Blind, Placebo-Controlled Trial of Bupropion Add-on to Olanzapine or Risperidone in Overweight Individuals With Schizophrenia. J Clin Psychopharmacol 2021;41:629-31. [PMID: 34735098 DOI: 10.1097/JCP.0000000000001481] [Reference Citation Analysis]
23 Koller D, Almenara S, Mejía G, Saiz-Rodríguez M, Zubiaur P, Román M, Ochoa D, Navares-Gómez M, Santos-Molina E, Pintos-Sánchez E, Abad-Santos F. Metabolic Effects of Aripiprazole and Olanzapine Multiple-Dose Treatment in a Randomised Crossover Clinical Trial in Healthy Volunteers: Association with Pharmacogenetics. Adv Ther 2021;38:1035-54. [PMID: 33278020 DOI: 10.1007/s12325-020-01566-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
24 Burin LM, Hahn MK, da Rocha NS, van Amelsvoort T, Bartels-Velthuis AA, Bruggeman R, de Haan L, Schirmbeck F, Simons CJP, van Os J, Cahn W. Long-term treatment of antipsychotics and combined therapy with other psychotropic medications inducing weight gain in patients with non-affective psychotic disorder: Evidence from GROUP, a longitudinal study. Psychiatry Res 2022;314:114680. [PMID: 35753222 DOI: 10.1016/j.psychres.2022.114680] [Reference Citation Analysis]
25 Regan AS, Valcourt SC. Metabolic Syndrome in Bipolar Disorder: Review and Management. Psychiatric Annals 2020;50:334-9. [DOI: 10.3928/00485713-20200713-01] [Reference Citation Analysis]
26 Chang SC, Goh KK, Lu ML. Metabolic disturbances associated with antipsychotic drug treatment in patients with schizophrenia: State-of-the-art and future perspectives. World J Psychiatr 2021; 11(10): 696-710 [PMID: 34733637 DOI: 10.5498/wjp.v11.i10.696] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
27 De Berardis D, Rapini G, Olivieri L, Di Nicola D, Tomasetti C, Valchera A, Fornaro M, Di Fabio F, Perna G, Di Nicola M, Serafini G, Carano A, Pompili M, Vellante F, Orsolini L, Martinotti G, Di Giannantonio M. Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine. Ther Adv Drug Saf 2018;9:237-56. [PMID: 29796248 DOI: 10.1177/2042098618756261] [Cited by in Crossref: 65] [Cited by in F6Publishing: 49] [Article Influence: 16.3] [Reference Citation Analysis]
28 Javed A, Arthur H, Curtis L, Hansen L, Pappa S. Practical Guidance on the Use of Lurasidone for the Treatment of Adults with Schizophrenia. Neurol Ther 2019;8:215-30. [PMID: 31098889 DOI: 10.1007/s40120-019-0138-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
29 Mukherjee S, Skrede S, Milbank E, Andriantsitohaina R, López M, Fernø J. Understanding the Effects of Antipsychotics on Appetite Control. Front Nutr 2021;8:815456. [PMID: 35047549 DOI: 10.3389/fnut.2021.815456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Rossom RC, O'Connor PJ, Crain AL, Waring S, Ohnsorg K, Taran A, Kopski K, Sperl-Hillen JM. Pragmatic trial design of an intervention to reduce cardiovascular risk in people with serious mental illness. Contemp Clin Trials 2020;91:105964. [PMID: 32087336 DOI: 10.1016/j.cct.2020.105964] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Emsley R, du Plessis S, Phahladira L, Luckhoff HK, Scheffler F, Kilian S, Smit R, Buckle C, Chiliza B, Asmal L. Antipsychotic treatment effects and structural MRI brain changes in schizophrenia. Psychol Med 2021;:1-10. [PMID: 35441587 DOI: 10.1017/S0033291721003809] [Reference Citation Analysis]
32 Ullagaddi MB, Patil BM, Khanal P. Beneficial effect of Zingiber officinale on olanzapine-induced weight gain and metabolic changes. J Diabetes Metab Disord 2021;20:41-8. [PMID: 34178822 DOI: 10.1007/s40200-020-00695-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Pochiero I, Calisti F, Comandini A, Del Vecchio A, Costamagna I, Rosignoli MT, Cattaneo A, Nunna S, Peduto I, Heiman F, Chang HC, Chen CC, Correll C. Impact of Lurasidone and Other Antipsychotics on Body Weight: Real-World, Retrospective, Comparative Study of 15,323 Adults with Schizophrenia. Int J Gen Med 2021;14:4081-94. [PMID: 34366678 DOI: 10.2147/IJGM.S320611] [Reference Citation Analysis]
34 Aslanoglou D, Bertera S, Sánchez-Soto M, Benjamin Free R, Lee J, Zong W, Xue X, Shrestha S, Brissova M, Logan RW, Wollheim CB, Trucco M, Yechoor VK, Sibley DR, Bottino R, Freyberg Z. Dopamine regulates pancreatic glucagon and insulin secretion via adrenergic and dopaminergic receptors. Transl Psychiatry 2021;11:59. [PMID: 33589583 DOI: 10.1038/s41398-020-01171-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
35 Wang J, Zhang Y, Yang Y, Liu Z, Xia L, Li W, Li Z, Xie X, Deng W, Zhang K, Liu H. The prevalence and independent influencing factors of obesity and underweight in patients with schizophrenia: a multicentre cross-sectional study. Eat Weight Disord 2021;26:1365-74. [PMID: 32557379 DOI: 10.1007/s40519-020-00920-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
36 Anthony J, Kinnafick F, Papathomas A, Breen K. Physical activity for adolescents with severe mental illness: a systematic scoping review. International Review of Sport and Exercise Psychology. [DOI: 10.1080/1750984x.2020.1833360] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Khandker R, Chekani F, Limone B, Thiel E. Cardiometabolic outcomes among schizophrenia patients using antipsychotics: the impact of high weight gain risk vs low weight gain risk treatment. BMC Psychiatry 2022;22. [DOI: 10.1186/s12888-022-03746-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
38 Dipta P, Sarsenbayeva A, Shmuel M, Forno F, Eriksson JW, Pereira MJ, Abalo XM, Wabitsch M, Thaysen-andersen M, Tirosh B. Macrophage-derived secretome is sufficient to confer olanzapine-mediated insulin resistance in human adipocytes. Comprehensive Psychoneuroendocrinology 2021;7:100073. [DOI: 10.1016/j.cpnec.2021.100073] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Poojari PG, Khan S, Shenoy S, Shetty S, Bose S, Pai K, Acharya LD, Thunga G. A narrative review of metabolic monitoring of adult prescribed second-generation antipsychotics for severe mental illness. Clinical Epidemiology and Global Health 2022;15:101035. [DOI: 10.1016/j.cegh.2022.101035] [Reference Citation Analysis]
40 Koricanac A, Borovcanin MM, Lucic AT. Еffects of Antipsychotics on Bone Mineral Density in Schizophrenia. Serbian Journal of Experimental and Clinical Research 2018;0:000010247820180036. [DOI: 10.2478/sjecr-2018-0036] [Reference Citation Analysis]
41 Xu Y, Lu Y, Cassidy RM, Mangieri LR, Zhu C, Huang X, Jiang Z, Justice NJ, Xu Y, Arenkiel BR, Tong Q. Identification of a neurocircuit underlying regulation of feeding by stress-related emotional responses. Nat Commun 2019;10:3446. [PMID: 31371721 DOI: 10.1038/s41467-019-11399-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
42 Hakami AY, Felemban R, Ahmad RG, Al-Samadani AH, Salamatullah HK, Baljoon JM, Alghamdi LJ, Ramadani Sindi MH, Ahmed ME. The Association Between Antipsychotics and Weight Gain and the Potential Role of Metformin Concomitant Use: A Retrospective Cohort Study. Front Psychiatry 2022;13:914165. [PMID: 35686187 DOI: 10.3389/fpsyt.2022.914165] [Reference Citation Analysis]
43 Aljawadi MH, Khoja AT, BaHammam AS, Alyahya NM, Alkhalifah MK, AlGhmadi OK. Determining the prevalence of symptoms and risk of obstructive sleep apnoea among old Saudis. J Taibah Univ Med Sci 2021;16:402-12. [PMID: 34140868 DOI: 10.1016/j.jtumed.2020.10.024] [Reference Citation Analysis]
44 Kim YH, Ryu S, Nam HJ, Kim M, Jhon M, Lee JY, Kim JM, Shin MH, Chung YC, Kim SW. The Psychology of Food Cravings in Patients With First-Episode Psychosis. Front Psychiatry 2020;11:587486. [PMID: 33362604 DOI: 10.3389/fpsyt.2020.587486] [Reference Citation Analysis]
45 da Cruz Jung IE, da Cruz IBM, Barbisan F, Trott A, Houenou LJ, Osmarin Turra B, Duarte T, de Souza Praia R, Maia-Ribeiro EA, da Costa Escobar Piccoli J, Bica CG, Duarte MMMF. Superoxide imbalance triggered by Val16Ala-SOD2 polymorphism increases the risk of depression and self-reported psychological stress in free-living elderly people. Mol Genet Genomic Med 2020;8:e1080. [PMID: 31891227 DOI: 10.1002/mgg3.1080] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
46 Schmitz A, Botner B, Hund M. Bupropion With Clozapine: Case Reports of Seizure After Coadministration. J Pharm Pract 2021;34:497-502. [PMID: 32079452 DOI: 10.1177/0897190020904280] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Brown B, Turkoz I, Mancevski B, Mathews M. Evaluation of paliperidone palmitate long-acting injectable antipsychotic therapy as an early treatment option in patients with schizophrenia. Early Interv Psychiatry 2020;14:428-38. [PMID: 31515972 DOI: 10.1111/eip.12868] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Renaldi R, Kim M, Lee TH, Kwak YB, Tanra AJ, Kwon JS. Predicting Symptomatic and Functional Improvements over 1 Year in Patients with First-Episode Psychosis Using Resting-State Electroencephalography. Psychiatry Investig 2019;16:695-703. [PMID: 31429218 DOI: 10.30773/pi.2019.06.20.1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
49 Abd El-hameed AM, Eskandrani AA, Elroby FA. Assessment of the ameliorative effect of Hypericum perforatum on olanzapine-induced hepatic oxidative stress and metabolic abnormalities in experimental male albino rats. Journal of Taibah University for Science 2020;14:1496-502. [DOI: 10.1080/16583655.2020.1834757] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
50 Citrome L, McEvoy JP, Todtenkopf MS, McDonnell D, Weiden PJ. A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future. Neuropsychiatr Dis Treat 2019;15:2559-69. [PMID: 31564881 DOI: 10.2147/NDT.S209284] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 7.7] [Reference Citation Analysis]
51 Skonieczna-Żydecka K, Łoniewski I, Stachowska E, Marlicz W, Correll CU. Current and Novel Approaches to Mitigate Cardiometabolic Adverse Effects of Second-Generation Antipsychotics. Int J Neuropsychopharmacol 2020;23:491-5. [PMID: 32239144 DOI: 10.1093/ijnp/pyaa026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Chang YH, Yang HY, Shun SC. Effect of exercise intervention dosage on reducing visceral adipose tissue: a systematic review and network meta-analysis of randomized controlled trials. Int J Obes (Lond) 2021;45:982-97. [PMID: 33558643 DOI: 10.1038/s41366-021-00767-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
53 Gandhi AA, Wilson TA, Sisley S, Elsea SH, Foster RH. Relationships between food-related behaviors, obesity, and medication use in individuals with Smith-Magenis syndrome. Res Dev Disabil 2022;127:104257. [PMID: 35597045 DOI: 10.1016/j.ridd.2022.104257] [Reference Citation Analysis]
54 Bazo-Alvarez JC, Morris TP, Carpenter JR, Hayes JF, Petersen I. Effects of long-term antipsychotics treatment on body weight: A population-based cohort study. J Psychopharmacol 2020;34:79-85. [PMID: 31724905 DOI: 10.1177/0269881119885918] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
55 Harvey PD, Nakamura H, Miura S. Blonanserin vs risperidone in Japanese patients with schizophrenia: A post hoc analysis of a phase 3, 8-week, multicenter, double-blind, randomized controlled study. Neuropsychopharmacol Rep 2020;40:63-72. [PMID: 31788985 DOI: 10.1002/npr2.12089] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
56 Khandker R, Shepherd J, Chekani F, Qureshi Z, Bailey H, Berry M, Wright J, Massey L. Atypical Treatment Switches in Schizophrenia Patients: Drivers and Associated Outcomes. NDT 2022;Volume 18:1057-67. [DOI: 10.2147/ndt.s358392] [Reference Citation Analysis]
57 Wills KH, Behan SJ, Nance MJ, Dawson JL, Polasek TM, Hopkins AM, van Dyk M, Rowland A. Combining Therapeutic Drug Monitoring and Pharmacokinetic Modelling Deconvolutes Physiological and Environmental Sources of Variability in Clozapine Exposure. Pharmaceutics 2021;14:47. [PMID: 35056943 DOI: 10.3390/pharmaceutics14010047] [Reference Citation Analysis]
58 Yang F, Chen L, Fang X, Zheng K, Zhu C, Xu C, Zhang C, Tang W. Influence of olanzapine on serum prolactin levels and BMI in female patients with schizophrenia. Neuropsychiatr Dis Treat 2018;14:3373-9. [PMID: 30587989 DOI: 10.2147/NDT.S180303] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
59 Qureshi ZP, Khandker R, Shepherd J, Samant S, Chekani F, Bailey HML. Assessment of Real-Life Outcomes in Schizophrenia Patients according to Compliance. Psychiatry J 2020;2020:5848601. [PMID: 32934955 DOI: 10.1155/2020/5848601] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
60 Kapur MK, Zalpuri I, Tran S, Singh MK. Treating Depression in the Context of Mania or Mania Risk in Youth. Curr Treat Options Psych 2020;7:400-15. [DOI: 10.1007/s40501-020-00225-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 Libowitz MR, Nurmi EL. The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children. Front Psychiatry 2021;12:623681. [PMID: 33776816 DOI: 10.3389/fpsyt.2021.623681] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Rojnic Kuzman M, Bosnjak Kuharic D, Kekin I, Makaric P, Madzarac Z, Koricancic Makar A, Kudlek Mikulic S, Bajic Z, Bistrovic P, Bonacin D, Vogrinc Z. Effects of Long-Term Multimodal Psychosocial Treatment on Antipsychotic-Induced Metabolic Changes in Patients With First Episode Psychosis. Front Psychiatry 2018;9:488. [PMID: 30386261 DOI: 10.3389/fpsyt.2018.00488] [Reference Citation Analysis]
63 Smith J, Griffiths LA, Band M, Hird-Smith R, Williams B, Bold J, Bradley E, Dilworth R, Horne D. Early Intervention in Psychosis: Effectiveness and Implementation of a Combined Exercise and Health Behavior Intervention Within Routine Care. Front Endocrinol (Lausanne) 2020;11:577691. [PMID: 33193094 DOI: 10.3389/fendo.2020.577691] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Huo T, Li Q, Cardel MI, Bussing R, Winterstein AG, Lemas DJ, Xu H, Woodard J, Mistry K, Scholle S, Muller KE, Shenkman EA. Enhancing Quality Measurement With Clinical Information: A Use Case of Body Mass Index Change Among Children Taking Second Generation Antipsychotics. Acad Pediatr 2022;22:S140-9. [PMID: 35339240 DOI: 10.1016/j.acap.2021.11.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Flanagan RJ, Lally J, Gee S, Lyon R, Every-Palmer S. Clozapine in the treatment of refractory schizophrenia: a practical guide for healthcare professionals. Br Med Bull 2020;135:73-89. [PMID: 32885238 DOI: 10.1093/bmb/ldaa024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
66 Silverstein SM, Fradkin SI, Demmin DL. Schizophrenia and the retina: Towards a 2020 perspective. Schizophrenia Research 2020;219:84-94. [DOI: 10.1016/j.schres.2019.09.016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
67 Bretler T, Weisberg H, Koren O, Neuman H. The effects of antipsychotic medications on microbiome and weight gain in children and adolescents. BMC Med 2019;17:112. [PMID: 31215494 DOI: 10.1186/s12916-019-1346-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
68 Ashraf GM, Alghamdi BS, Alshehri FS, Alam MZ, Tayeb HO, Tarazi FI. Empagliflozin Effectively Attenuates Olanzapine-Induced Body Weight Gain in Female Wistar Rats. Front Pharmacol 2021;12:578716. [PMID: 33953666 DOI: 10.3389/fphar.2021.578716] [Reference Citation Analysis]
69 Chua MWJ. An old ally to address the "triple threat". Am J Med 2021:S0002-9343(21)00739-7. [PMID: 34808101 DOI: 10.1016/j.amjmed.2021.10.032] [Reference Citation Analysis]